Abington Heights Sophomore Kale Bonnewell took the polar plunge to support Special Olympics. “I really liked being a part of ...

CBSE Board Exam 2026 Live: Class 10, 12 exam begins at 10.30 am across the country and abroad. Follow the blog for latest updates on exam day guidelines, students reactions, paper analysis and more.

Clinical decision support (CDS) software plays an increasingly central role in health-care delivery, yet the ambiguous interpretations of regulations result in inconsistent application in clinical ...

CBSE Class 10 Science Board Exam 2026 is of 80 marks, divided into Biology (30), Chemistry (25), and Physics (25). Life Processes, Metals & Non-metals, Electricity, and Light carry the highest ...

International Business Machines stock is getting slammed Monday, becoming the latest perceived victim of rapidly developing AI technology, after Anthropic said its Claude Code tool could be used to ...

CBSE Class 10th Computer Application Sample Paper 2025-26 is available here. The Computer Applications exam is scheduled to be held on 27th February, and as the exam approaches, students should start ...

Immigration: The Supreme Court declined to immediately allow the Trump administration to end Temporary Protected Status for ...

TIOBE Index for March 2026: Top 10 Most Popular Programming Languages Your email has been sent Python keeps the top spot as its rating dips again, C climbs further in second, and the bottom stays ...

Cemex announced today that it has reached an agreement to acquire all assets of Omega Products International ("Omega"), a ...

This study presents valuable findings that could potentially allow a deeper understanding of the immunopathogenesis underlying influenza infection in aged mice. The results are based on solid evidence ...

A flagship bill that would tighten Canada’s immigration and asylum rules should be gutted, with key sections removed to address concerns regarding human rights and privacy, a Senate committee has ...

UCB, a global biopharmaceutical company, today announced positive topline data from the BE BOLD trial assessing BIMZELX® (bimekizumab) versus SKYRIZI® (risankizumab) in adults with active psoriatic ...